Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001085146-25-001358·Immunocore Holdings plc
Schedule 13G ownership disclosure
IMMUNOCORE HOLDINGS PLC
ADR · CUSIP: 45258D105
Event date: 2024-12-31
- Filing-level shares
- 2,668,550
- Percent of class
- 5.33%
- PRIMECAP MANAGEMENT CO/CA/
Shares: 2,668,550 · Class: 5.33%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-001358
- Form type
- SCHEDULE 13G
- Filer
- Immunocore Holdings plc
- CIK
- CIK 1671927
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership